TB-500 Methionine Oxidation Kinetics & Multimerization Resistance

TB-500 is a synthetic 43-amino-acid peptide (Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser) with an exact molecular weight of 4963.50 g/mol. The molecule contains an N-terminal acetyl group and a solitary methionine residue at position 6 (Met6). When exposed to oxidative stress, the thioether side chain of Met6 undergoes nucleophilic reaction with reactive oxygen species, forming methionine sulfoxide (+16.0 Da, 4979.50 g/mol).

Forced degradation assays employing 0.1% to 1.0% (v/v) hydrogen peroxide (H2O2) demonstrate pseudo-first-order oxidation kinetics. At 25°C in 0.3% H2O2, the observed oxidation rate constant is kobs = 1.42 × 10⁻⁴ s⁻¹, corresponding to a 50% conversion of native TB-500 to Met6-sulfoxide within 81.3 minutes. High-resolution mass spectrometry confirms a +16 Da mass shift in the [M+4H]⁴⁺ precursor ion from m/z 1241.88 to m/z 1245.88.

Addition of sacrificial anti-oxidants stabilizes aqueous formulations. Incorporating 0.05% (w/v) L-methionine or 0.02% (w/v) ascorbic acid into reconstitution diluents suppresses peroxide-mediated oxidation by 94.2% over a 14-day incubation period at 4°C, maintaining primary analyte purity above 98.0%.

Evaluating peptide multimerization and higher-order aggregation requires calibrated size-exclusion chromatography (SEC). Assays utilize a Waters BioSuite High Resolution SEC column (300 mm × 7.8 mm, 4 µm particle size, 125 Å pore dimensions) operating with an isocratic mobile phase of 50 mM sodium phosphate and 150 mM sodium chloride at pH 6.8, pumped at 0.5 mL/min with UV detection at 214 nm.

Monomeric TB-500 elutes as a sharp, symmetrical peak at an elution volume of 9.42 mL (apparent molecular mass ~5.0 kDa against globular protein standards). Under standard reconstitution concentrations (2.0 mg/mL in bacteriostatic water), monomer content exceeds 99.1% with non-detectable dimer or oligomer formation. At elevated concentrations exceeding 8.0 mg/mL, secondary non-covalent association produces a minor shoulder peak at 8.15 mL (~10 kDa dimer).

Dynamic light scattering (DLS) confirms a monodisperse hydrodynamic radius (Rh) of 1.48 ± 0.06 nm at 25°C with a polydispersity index (PDI) below 0.08. Repeated freeze-thaw cycles (up to 5 cycles between -20°C and 4°C) generate no detectable sub-visible particulate matter or high-molecular-weight multimers, demonstrating exceptional conformational stability of the random-coil monomer.

Reversed-phase liquid chromatography of the 43-mer synthetic polypeptide utilizes a wide-pore Vydac 218TP C18 column (250 mm × 4.6 mm, 5 µm particle size, 300 Å pore size). Wide-pore silica is mandatory for peptides exceeding 3,000 g/mol to prevent restricted pore diffusion and peak broadening observed on standard 100 Å stationary phases. Column temperature is thermostatted at 35.0 ± 0.5°C.

The mobile phase gradient pairs Phase A (0.1% v/v trifluoroacetic acid in LC-MS water) with Phase B (0.085% v/v trifluoroacetic acid in acetonitrile). Elution follows a shallow gradient from 20% to 40% Phase B over 25 minutes at a constant flow rate of 1.0 mL/min, with UV monitoring at 214 nm. Native TB-500 elutes at 16.40 ± 0.15 minutes with a peak asymmetry factor of 1.14.

Under these chromatographic conditions, Met6-sulfoxide degradant elutes at 15.10 minutes (relative retention time RRT 0.92) with a baseline resolution factor Rs greater than 2.4. Acetylated deletion impurities (e.g., des-Ser1-TB-500 and des-Lys3-TB-500) resolve cleanly on the leading and trailing peak shoulders, ensuring accurate limit of quantitation (LOQ = 0.05 µg/mL).

Solid-state and aqueous thermal stability evaluations demonstrate distinct degradation kinetics governed by environmental temperature. Lyophilized cakes stored at -20°C in Type I amber vials sealed under nitrogen retain greater than 98.4% chromatographic purity after 24 months, with Karl Fischer residual moisture levels consistently below 1.2% w/w.

In reconstituted aqueous solution (2.0 mg/mL in 0.9% bacteriostatic water), refrigerated storage at 4°C maintains peptide integrity above 97.5% across 28 days. Elevated thermal storage at 40°C triggers deamidation of Gln23 and Gln36 residues to glutamic acid derivatives, accelerating purity loss to 8.4% within 7 days. Buffer systems maintaining pH between 5.5 and 7.0 minimize both deamidation and peptide backbone hydrolysis.

Photodegradation experiments conducted under ICH Q1B guidelines (1.2 million lux-hours visible light, 200 watt-hours/m² UV-A) show no measurable degradation for amber glass vials. Conversely, clear glass vials exhibit 6.8% loss in chromatographic purity over 48 hours, demonstrating the necessity of amber containment during storage and bench manipulation.

In vitro enzymatic degradation assays evaluate the proteolytic vulnerability of TB-500 against human plasma and simulated physiological fluids. Reconstituted peptide aliquots (100 µg/mL) incubated at 37°C in simulated gastric fluid (0.2% NaCl, 0.32% pepsin, pH 1.2 adjusted with HCl) degrade rapidly, exhibiting complete proteolytic digestion within 15 minutes due to multiple cleavages at Leu and Phe residues.

In neutral simulated intestinal fluid (USP pancreatin, pH 6.8), endopeptidases hydrolyze the peptide into smaller oligomeric fragments within 45 minutes. Conversely, in sterile in vitro physiological buffer (PBS, pH 7.4) free of active proteases, TB-500 exhibits remarkable chemical stability, retaining greater than 98.0% intact monomer across 72 hours of continuous 37°C incubation.

Mass spectrometric identification of enzymatic breakdown products identifies primary cleavage sites between Asp5-Met6, Phe12-Asp13, and Leu28-Pro29. These empirical findings confirm that synthetic TB-500 must be maintained in protease-free analytical media and stored in neutral, refrigerated buffers to prevent enzymatic or hydrolytic breakdown.